Effectiveness of Arginine as a Treatment for Sickle Cell Anemia
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited genetic disease
that can cause intense pain episodes. This study will evaluate the effectiveness of the
nutritional supplement arginine at improving blood cell function and disease symptoms in
people with SCD.
Phase:
Phase 2
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI) UCSF Benioff Children's Hospital Oakland